COMPANY
New Health Sciences, Inc.
Funding and NIH signals
- NIH award NIH awarded $984K (SBIR Phase II 5R44HL178006-02, continuation, notice Sep 4, 2026). NIH RePORTER 5R44HL178006-02 (Sep 4, 2026)
Evidence (1 event)
- Sep 4, 2026 · NIH RePORTER 5R44HL178006-02
Organization: NEW HEALTH SCIENCES, INC.; City/State: Lexington, MA; Project number: 5R44HL178006-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-04; FY total cost (award amount): 984232; Administering IC: National Heart Lung and Blood Institute; Project title: Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia; Organization type: Domestic For-Profits
- Sep 4, 2026 · NIH RePORTER 5R44HL178006-02